Preview

Hygiene and Sanitation

Advanced search

Myocardial and microvascular remodeling in dust-related lung pathology as a morphological substrate of occupational cardiomyopathy in miners

https://doi.org/10.47470/0016-9900-2026-105-7-730-736

EDN: fwiain

Abstract

Introduction. Heart diseases are the leading cause of death among miners (>60%). Between 2000 and 2016, 1,797 acute cardiovascular events occurred at the workplace, including 467 fatal cases. These are usually classified as ischemic heart disease, but this is not confirmed by microscopy and does not account for direct damage to the heart by coal-rock dust.

Objective. To provide microscopic evidence for defining “dust cardiomyopathy” as a distinct occupational heart disease.

Materials and methods. Heart tissue from 80 miners (work experience from 1 to 30 years) and 30 age‑matched healthy controls was examined using histology, histochemistry, and immunohistochemistry (markers CD34, CD31, α-SMA, TGF-β1, Bcl-2) with morphometric measurements.

Results. With increasing work experience, microvessel walls thickened by 1.5–2.5 times, and endothelial cell area increased by 2–4 times. As early as 1–5 years of exposure, lipofuscin pigment appeared in cardiomyocytes (area 143.7±33.6 µm²), peaking at 12–20 years (159.6±33.4 µm²) — significantly higher than in controls (p<0.001). Cardiomyocyte diameter increased up to 20.02±4.66 µm, heart weight to 530–580 g. For the first time, there was demonstrated a sign of endothelial‑to‑mesenchymal transition as the appearance of CD31 and CD34 proteins in vessel walls.

Limitations. Autopsy remains the gold standard for determining the cause of death. Experimental animal studies also end with autopsy, which does not question their validity. The study was conducted only on material from Kuzbass, using samples from those who died in industrial catastrophes, which requires careful interpretation.

Conclusion. The obtained morphological data provide a scientific basis for distinguishing dust cardiomyopathy as an independent occupational heart disease. Its hallmarks are damage to the inner lining of vessels, perivascular fibrosis, and lipofuscin accumulation. Further clinical studies are needed for final confirmation.

Compliance with ethical standards. The protocol was approved by the local ethics committee (Protocol No. 4, 21.11.2024).

Contribution:
Bondarev O.I. — concept, design, writing, editing;
Filimonov E.S. — material collection, data processing, literature review.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.

Conflict of interest. The authors declare no conflict of interest.

Funding. The study had no sponsorship.

Received: April 24, 2026 / Revised: May 17, 2026 / Accepted: July 1, 2026 / Published: August 14, 2026

About the Authors

Oleg I. Bondarev
Research Institute for Complex Problems of Hygiene and Occupational Diseases; Novokuznetsk State Institute for Further Training of Physicians – Branch Campus of the Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
Russian Federation

DSc (Medicine), leading researcher, molecular-genetic and experimental study laboratory, Research Institute for Complex Problems of Hygiene and Occupational Diseases, Novokuznetsk, 654041, Russian Federation

e-mail: gis.bondarev@yandex.ru



Egor S. Filimonov
Research Institute for Complex Problems of Hygiene and Occupational Diseases
Russian Federation

PhD (Medicine), head, youth laboratory, Research Institute for Complex Problems of Hygiene nd Occupational Diseases, Novokuznetsk, 654041, Russian Federation

e-mail: 171fes@gmail.com



References

1. Tikhonova G.I., Piktushanskaya T.E., Gorchakova T.Yu., Churanova A.N., Bryleva M.S. Mortality study in a cohort of coal miners with occupational diseases. Meditsina truda i promyshlennaya ekologiya. 2017; 57(12): 6–11. https://elibrary.ru/zxhfgd (in Russian)

2. Tikhonova G.I., Piktushanskaya T.E., Gorchakova T.Yu., Serebryakov P.V. Life expectancy of coal miners with an established diagnosis of occupational diseases. Meditsina truda i promyshlennaya ekologiya. 2022; 62(6): 419–26. https://doi.org/10.31089/1026-9428-2022-62-6-419-426 https://elibrary.ru/ftodgs (in Russian)

3. Bukhtiyarov I.V., Golovkova N.P., Khelkovskii-Sergeev N.A., Kotova N.I. Causes and measures to prevent sudden death of workers in coal mines. In: Actual Problems of Occupational Medicine: Proceedings of the Institute [Aktual’nye problemy meditsiny truda: Sbornik trudov instituta]. Saratov; 2018: 341–50. (in Russian)

4. Bukhtiyarov I.V., Zibarev E.V., Vostrikova S.M., Kravchenko O.K., Piktushanskaya T.E., Kuznetsova E.A., et al. The current state of working conditions in coal mines of Russia. Meditsina truda i promyshlennaya ekologiya. 2023; 63(6): 348–58. https://doi.org/10.31089/1026-9428-2023-63-6-348-358 https://elibrary.ru/vxajap (in Russian)

5. Federal State Statistics Service. Demographic Yearbook of Russia – 2023: Statistical collection. Moscow: Rosstat; 2023: 156–62. (in Russian)

6. Golovkova N.P., Kuzmina L.P., Izmerova N.I., Leskina L.M., Tolmachev D.A., Varakuta I.S., et al. Priority directions for preserving the health of underground coal mining workers. Meditsina truda i promyshlennaya ekologiya. 2023; 63(12): 795–801. https://doi.org/10.31089/1026-9428-2023-63-12-795-801 https://elibrary.ru/nbzyjt (in Russian)

7. Tikhonova G.I., Piktushanskaya T.E., Gorchakova T.Yu., Churanova A.N., Bryleva M.S. Influence of duration and intensity of exposure to occupational hazards on mortality levels of coal miners. Meditsina truda i promyshlennaya ekologiya. 2018; 58(7): 16–21. https://doi.org/10.31089/1026-9428-2018-7-16-21 https://elibrary.ru/xuasff (in Russian)

8. Obukhova T.Yu., Gurvich V.B., Budkar L.N., Ustyantsev S.L., Solodushkin S.I., Karpova E.A., et al. Cardiovascular and metabolic disorders associated with occupational lung fibrosis in employees exposed to the dust at the workplace. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2020; 99(1): 97–102. https://elibrary.ru/fniqov (in Russian)

9. Zemets A.A. Clinical features of circulatory disorders in patients with pneumoconiosis. In: Proceedings of the XV All-Union Congress of Therapeutics [Trudy XV Vsesoyuznogo s”ezda terapevtov]. Moscow: Meditsina; 1964: 443–5. (in Russian)

10. Wang X., He B. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm (2020). 2024; 5(8): e651. https://doi.org/10.1002/mco2.651 https://elibrary.ru/pyjbla

11. Velusamy P., Buckley D.J., Greaney J.L., Case A.J., Fadel P.J., Trott D.W. IL-6 induces mitochondrial ROS production and blunts NO bioavailability in human aortic endothelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2025; 328(4): R509–14. https://doi.org/10.1152/ajpregu.00289.2024 https://elibrary.ru/zmtjqp

12. Velichkovsky B.T. Molecular and cellular foundations of ecological pulmonology. Pul’monologiya. 2000; (3): 10–8. (in Russian)

13. Goumans M.J., van Zonneveld A.J., ten Dijke P. Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? Trends Cardiovasc. Med. 2008; 18(8): 293–8. https://doi.org/10.1016/j.tcm.2009.01.001

14. Piera-Velazquez S., Jimenez S.A. Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol. Rev. 2019; 99(2): 1281–324. https://doi.org/10.1152/physrev.00021.2018 https://elibrary.ru/uptmex

15. Wang Z., Yang Y., Wang Q., Wang L., Zhao Y., Qian X., et al. Pathological mechanisms and clinical research progress of endothelial dysfunction. Front. Cardiovasc. Med. 2026; 13: 1749548. https://doi.org/10.3389/fcvm.2026.1749548 https://elibrary.ru/vlyyst

16. Höhn A., Grune T. Lipofuscin: formation, effects and role of macroautophagy. Redox. Biol. 2013; 1(1): 140–4. https://doi.org/10.1016/j.redox.2013.01.006

17. Ilie O.D., Ciobica A., Riga S., Dhunna N., McKenna J., Mavroudis I., et al. Mini-review on lipofuscin and aging: focusing on the molecular interface, the biological recycling mechanism, oxidative stress, and the gut-brain axis functionality. Medicina (Kaunas). 2020; 56(11): 626. https://doi.org/10.3390/medicina56110626 https://elibrary.ru/kbxvhk

18. Zhang J., Wirtz S. Does pyroptosis play a role in inflammasome-related disorders? Int. J. Mol. Sci. 2022; 23(18): 10453. https://doi.org/10.3390/ijms231810453 https://elibrary.ru/ethtop

19. Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025; 35(5): 334–44. https://doi.org/10.1038/s41422-025-01107-6 https://elibrary.ru/xhxjzn

20. Ajoolabady A., Pratico D., Ren J. Endothelial dysfunction: mechanisms and contribution to diseases. Acta Pharmacol. Sin. 2024; 45(10): 2023–31. https://doi.org/10.1038/s41401-024-01295-8 https://elibrary.ru/lacerv

21. Mikhailova N.N., Bondarev O.I., Bugaeva M.S. Pathomorphological changes in the vessels of the heart and the lungs in pneumoconiosis. Meditsina v Kuzbasse. 2017; 16(3): 37–41. https://elibrary.ru/zgiman (in Russian)

22. Kan S.L., Bondarev O.I., Kosovskikh A.A., Lukashev K.V., Zoloeva O.S., Ekimovskikh A.V., et al. Compensatory-adaptive mechanisms of changes in the endothelial system in miners of Kuzbass (clinical and morphological aspects). Meditsina v Kuzbasse. 2017; 16(3): 37–41. https://elibrary.ru/zgiman (in Russian)

23. Gurzu I.L., Handra C.M., Ghita I., Otelea M.R. Unveiling the threat of crystalline silica on the cardiovascular system. A comprehensive review of the current knowledge. Front. Cardiovasc. Med. 2025; 12: 1506846. https://doi.org/10.3389/fcvm.2025.1506846 https://elibrary.ru/blbdpm

24. Xu W., Ma R., Wang J., Sun D., Yu S., Ye Q. Pneumoconiosis combined with connective tissue disease in China: a cross-sectional study. BMJ Open. 2023; 13(4): e068628. https://doi.org/10.1136/bmjopen-2022-068628 https://elibrary.ru/rutxlu

25. Ding P., Song Y., Yang Y., Zeng C. NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention. Front. Pharmacol. 2024; 15: 1368835. https://doi.org/10.3389/fphar.2024.1368835 https://elibrary.ru/ftxmpr

26. Toldo S., Abbate A. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat. Rev. Cardiol. 2024; 21(4): 219–37. https://doi.org/10.1038/s41569-023-00946-3 https://elibrary.ru/qcgjkq

27. European Commission. Information notices on occupational diseases: a guide to diagnosis; 2009.


Review

For citations:


Bondarev O.I., Filimonov E.S. Myocardial and microvascular remodeling in dust-related lung pathology as a morphological substrate of occupational cardiomyopathy in miners. Hygiene and Sanitation. 2026;105(7):730-736. (In Russ.) https://doi.org/10.47470/0016-9900-2026-105-7-730-736. EDN: fwiain

Views: 245

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0016-9900 (Print)
ISSN 2412-0650 (Online)
X